Literature DB >> 24363520

Cooperative inhibitory effect of sinomenine combined with 5-fluorouracil on esophageal carcinoma.

Jing Wang1, Zi-Rong Yang1, Wei-Guo Dong1, Ji-Xiang Zhang1, Xu-Feng Guo1, Jia Song1, Shi Qiu1.   

Abstract

AIM: To investigate the inhibitory effects of sinomenine (SIN) combined with 5-fluorouracil (5-FU) on esophageal carcinoma in vitro and in vivo.
METHODS: Esophageal carcinoma (Eca-109) cells were cultured in DMEM. The single or combined growth inhibition effects of SIN and 5-FU on the Eca-109 cells were examined by measuring the absorbance of CCK-8 dye in living cells. Hoechst 33258 staining and an Annexin V/PI apoptosis kit were used to detect the percentage of cells undergoing apoptosis. Western blotting was used to investigate the essential mechanism underlying SIN and 5-FU-induced apoptosis. SIN at 25 mg/kg and 5-FU at 12 mg/kg every 3 d, either combined or alone, was injected into nude mice and tumor growth inhibition and side effects of the drug treatment were observed.
RESULTS: SIN and 5-FU, both in combination and individually, significantly inhibited the proliferation of Eca-109 cells and induced obvious apoptosis. Furthermore, the combined effects were greater than those of the individual agents (P < 0.05). Annexin V/PI staining and Hoechst 33258 staining both indicated that the percentage of apoptotic cells induced by SIN and 5-FU combined or alone were significantly different from the control (P < 0.05). The up-regulation of Bax and down-regulation of Bcl-2 showed that the essential mechanism of apoptosis induced by SIN and 5-FU occurs via the mitochondrial pathway. SIN and 5-FU alone significantly inhibited the growth of tumor xenografts in vivo, and the combined inhibition rate was even higher (P < 0.05). During the course of chemotherapy, no obvious side effects were observed in the liver or kidneys.
CONCLUSION: The combined effects of SIN and 5-FU on esophageal carcinoma were superior to those of the individual compounds, and the drug combination did not increase the side effects of chemotherapy.
© 2013 Baishideng Publishing Group Co., Limited. All rights reserved.

Entities:  

Keywords:  5-Fluorouracil; Chemotherapy; Esophageal carcinoma; Sinomenine

Mesh:

Substances:

Year:  2013        PMID: 24363520      PMCID: PMC3857452          DOI: 10.3748/wjg.v19.i45.8292

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

Review 1.  Molecular pathways and targets in cancer-related inflammation.

Authors:  Alberto Mantovani; Cecilia Garlanda; Paola Allavena
Journal:  Ann Med       Date:  2010-04       Impact factor: 4.709

2.  In vitro pharmacological actions of sinomenine on the smooth muscle and the endothelial cell activity in rat aorta.

Authors:  Seiichiro Nishida; Hiroyasu Satoh
Journal:  Life Sci       Date:  2006-03-27       Impact factor: 5.037

3.  The anti-angiogenic effect of sinomenine.

Authors:  T W Kok; Patrick Y K Yue; N K Mak; T P D Fan; L Liu; Ricky N S Wong
Journal:  Angiogenesis       Date:  2005       Impact factor: 9.596

4.  Apoptosis of colorectal adenocarcinoma induced by 5-FU and/or IFN-gamma through caspase 3 and caspase 8.

Authors:  Y Adachi; S Taketani; H Oyaizu; K Ikebukuro; R Tokunaga; S Ikehara
Journal:  Int J Oncol       Date:  1999-12       Impact factor: 5.650

5.  Protective effects of fermented ginseng on streptozotocin-induced pancreatic beta-cell damage through inhibition of NF-kappaB.

Authors:  Hai-Dan Yuan; Sung-Hyun Chung
Journal:  Int J Mol Med       Date:  2010-01       Impact factor: 4.101

6.  Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study.

Authors:  Yoshihiro Tanaka; Kazuhiro Yoshida; Yuichi Sanada; Shinji Osada; Kazuya Yamaguchi; Takao Takahashi
Journal:  Cancer Chemother Pharmacol       Date:  2010-09-28       Impact factor: 3.333

7.  COX-2 polymorphisms in patients with familial adenomatous polyposis.

Authors:  Wilbert H M Peters; Rene H M te Morsche; Hennie M J Roelofs; Elisabeth M H Mathus-Vliegen; Marloes Berkhout; Fokko M Nagengast
Journal:  Oncol Res       Date:  2009       Impact factor: 5.574

8.  Combined modality therapy in esophageal cancer: the Memorial experience.

Authors:  Sibyl E Anderson; Bruce D Minsky; Manjit Bains; David P Kelsen; David H Ilson
Journal:  Semin Surg Oncol       Date:  2003

9.  Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase.

Authors:  Li Qian; Zongli Xu; Wei Zhang; Belinda Wilson; Jau-Shyong Hong; Patrick M Flood
Journal:  J Neuroinflammation       Date:  2007-09-19       Impact factor: 8.322

10.  Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil.

Authors:  K H Yeh; S H Yeh; C H Hsu; T M Wang; I F Ma; A L Cheng
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

View more
  12 in total

Review 1.  Mechanism Underlying Antitumor Effects of Sinomenine.

Authors:  Le-Nyu Gao; Bing Zhong; Yong Wang
Journal:  Chin J Integr Med       Date:  2019-03-01       Impact factor: 1.978

2.  Preparation, Synergism, and Biocompatibility of in situ Liquid Crystals Loaded with Sinomenine and 5-Fluorouracil for Treatment of Liver Cancer.

Authors:  Jiaojiao Cao; Jie Huang; Shuangying Gui; Xiaoqin Chu
Journal:  Int J Nanomedicine       Date:  2021-05-31

3.  Myricetin enhance chemosensitivity of 5-fluorouracil on esophageal carcinoma in vitro and in vivo.

Authors:  Lei Wang; Jianfang Feng; Xiaonan Chen; Wei Guo; Yuwen Du; Yuanyuan Wang; Wenqiao Zang; Shijie Zhang; Guoqiang Zhao
Journal:  Cancer Cell Int       Date:  2014-07-18       Impact factor: 5.722

4.  Volatile Oil from Amomi Fructus Attenuates 5-Fluorouracil-Induced Intestinal Mucositis.

Authors:  Ting Zhang; Shan H Lu; Qian Bi; Li Liang; Yan F Wang; Xing X Yang; Wen Gu; Jie Yu
Journal:  Front Pharmacol       Date:  2017-11-09       Impact factor: 5.810

5.  Sinomenine hydrochloride inhibits cell survival in human hepatoma Huh7 cells.

Authors:  Ying Wang; Ming Li; Xuesong Yu; Ali Chen; Ying Ding; Yan Wang; Yan Wang
Journal:  Biomed Rep       Date:  2018-04-02

Review 6.  Therapeutic Inducers of Apoptosis in Ovarian Cancer.

Authors:  Mudra Binju; Monica Angelica Amaya-Padilla; Graeme Wan; Hendra Gunosewoyo; Yohan Suryo Rahmanto; Yu Yu
Journal:  Cancers (Basel)       Date:  2019-11-13       Impact factor: 6.639

7.  Sinomenine sensitizes human gastric cancer cells to cisplatin through negative regulation of PI3K/AKT/Wnt signaling pathway.

Authors:  Ying Liu; Changqing Liu; Ting Tan; Shang Li; Shunyu Tang; Xingyin Chen
Journal:  Anticancer Drugs       Date:  2019-11       Impact factor: 2.248

8.  C16, a novel sinomenine derivatives, promoted macrophage reprogramming toward M2-like phenotype and protected mice from endotoxemia.

Authors:  Ping Ni; Yue-Qin Liu; Jin-Yu Man; Wang Li; Shan-Shan Xue; Tao-Hong Lu; Zhao-Liang Su; Cheng-Lin Zhou
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

9.  Sinomenine Induces G1-Phase Cell Cycle Arrest and Apoptosis in Malignant Glioma Cells Via Downregulation of Sirtuin 1 and Induction of p53 Acetylation.

Authors:  Xiaoyan He; Mayinur Maimaiti; Yan Jiao; Xuegang Meng; Hongyan Li
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

10.  Enhancing conventional chemotherapy drug cisplatin-induced anti-tumor effects on human gastric cancer cells both in vitro and in vivo by Thymoquinone targeting PTEN gene.

Authors:  Jingjing Ma; Xue Hu; Jiao Li; Dandan Wu; Qingzhi Lan; Qian Wang; Shan Tian; Weiguo Dong
Journal:  Oncotarget       Date:  2017-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.